Evidence on the cost of breast cancer drugs is required for rational decision making

BACKGROUND: For rational decision making, assessing the cost-effectiveness and budget impact of new drugs and comparing the costs of drugs already on the market is required. In addition to value frameworks, such as the American Society of Clinical Oncology Value Framework and the European Society of...

Descripción completa

Detalles Bibliográficos
Autores principales: Berghuis, Anne Margreet Sofie, Koffijberg, Hendrik, Terstappen, Leonardus Wendelinus Mathias Marie, Sleijfer, Stefan, IJzerman, Maarten Joost
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cancer Intelligence 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5931813/
https://www.ncbi.nlm.nih.gov/pubmed/29743945
http://dx.doi.org/10.3332/ecancer.2018.825

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5931813/
https://www.ncbi.nlm.nih.gov/pubmed/29743945
http://dx.doi.org/10.3332/ecancer.2018.825

Ejemplares similares